Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 27,826 shares at $5.32 ($148K) on 2022-05-17, disclosed to the SEC on 2022-05-19.
Open-market sale of $148k ATRA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.32 | 13,913 | $74K | 50.0% |
| 2 | $5.32 | 13,913 | $74K | 50.0% |
| Total | $5.32 avg | 27,826 | $148K | 100% |
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |